6MK

Merck & Co., Inc. · BX:6MK

123.14 CHF5.10 +4.32%

Merck & Co., Inc. (BX:6MK) last traded at 123.14 CHF, up 4.32% on the day. Over the past year the stock is up 77.87%. Its 52-week range is 66.81 to 125.91. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open123.14

Day range123.14 – 123.14

52-week range66.81 – 125.91

Volume16

Average volume (10 days)26

Market cap (USD)368.89 B

P/E150.44

EPS (TTM) (USD)0.9792

Dividend yield2.27%

Revenue (TTM) (USD)67.19 B

Employees75.00 K

Performance

+2.50%1 week

+3.58%1 month

+19.44%3 months

+38.75%6 months

+46.90%Year to date

+77.87%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Merck Stocks Decline With Higher Target Leaving a New-Launch Scale TestGuruFocus · 02 Nov 2026
Merck Is Maintained at Neutral by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
Merck to Present New Data from Its Broad Oral HIV Portfolio and Pipeline at HIV Glasgow 2026BusinessWire · 02 Nov 2026
From Near Miss To Crown Jewel: The Rise, Reign And Road Ahead For Merck's Keytrudadpa-AFX · 01 Nov 2026
Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Merck Price Target Raised to $175.00/Share From $165.00 by JP MorganDow Jones Newswires · 30 Oct 2026
Merck Stocks Rise 2.6% With Qlex Still Under 10% of Keytruda SalesGuruFocus · 30 Oct 2026
Merck One of Top Large-Cap Biopharma Picks-AnalystBenzinga · 30 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.